Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/c2/37/b9/c237b9d2-8e2a-b146-02d3-02b2268c757f/mza_5549193924744907528.jpg/600x600bb.jpg
PeerVoice Endocrinology & Metabolic Disorders Audio
PeerVoice
51 episodes
2 days ago
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
RSS
All content for PeerVoice Endocrinology & Metabolic Disorders Audio is the property of PeerVoice and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/c2/37/b9/c237b9d2-8e2a-b146-02d3-02b2268c757f/mza_5549193924744907528.jpg/600x600bb.jpg
Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis
PeerVoice Endocrinology & Metabolic Disorders Audio
18 minutes 48 seconds
4 months ago
Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis
Visit https://www.peervoice.com/BAN860 to view the entire programme with slides. After completing “Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis”, participants will be able to: Explain the mechanistic rationale for OX40 pathway inhibitors in atopic dermatitis (AD); Describe the benefits and limitations of current disease management strategies in AD; and Use clinical data to evaluate the effects of emerging OX40 inhibitors for patients with AD in the context of current clinical management.
PeerVoice Endocrinology & Metabolic Disorders Audio
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.